{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T01:46:26Z","timestamp":1789004786760,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.biopha.2025.117841","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T15:49:31Z","timestamp":1736783371000},"page":"117841","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Diketopiperazine\/piperidine alkaloid as a potential broad-spectrum coronaviral entry inhibitor identified by supercomputer-based virtual screening from a large natural product-based library"],"prefix":"10.1016","volume":"183","author":[{"given":"Nasim","family":"Shahhamzehei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Abdelfatah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ejlal A.","family":"Omer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Riedl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Meesters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah S.","family":"Schwarzer-Sperber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Sutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Bringmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Schwarzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Efferth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.117841_bib1","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.bj.2020.04.007","article-title":"COVID-19: The first documented coronavirus pandemic in history","volume":"43","author":"Liu","year":"2020","journal-title":"Biomed. J."},{"key":"10.1016\/j.biopha.2025.117841_bib2","series-title":"Number of COVID-19 Cases Reported to WHO (Cumulative total) World","author":"WHO","year":"2024"},{"key":"10.1016\/j.biopha.2025.117841_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12985-023-01973-9","article-title":"An overview on the treatments and prevention against COVID-19","volume":"20","author":"Panahi","year":"2023","journal-title":"Virol. J."},{"key":"10.1016\/j.biopha.2025.117841_bib4","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41586-023-06753-7","article-title":"Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting","volume":"625","author":"Yisimayi","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.117841_bib5","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/phn.13134","article-title":"Vaccination hesitancy: to be vaccinated, or not to be vaccinated, that is the question in the era of COVID-19","volume":"40","author":"Perrone","year":"2023","journal-title":"Public Health Nurs."},{"key":"10.1016\/j.biopha.2025.117841_bib6","first-page":"1","article-title":"Outcomes of SARS-CoV-2 reinfection","author":"Al-Aly","year":"2022","journal-title":"Res. Sq."},{"key":"10.1016\/j.biopha.2025.117841_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106201","article-title":"COVID-19 and the promise of small molecule therapeutics: are there lessons to be learnt?","volume":"179","author":"Ho","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2025.117841_bib8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.coviro.2021.08.010","article-title":"Structure of SARS-CoV-2 spike protein","volume":"50","author":"Zhang","year":"2021","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.biopha.2025.117841_bib9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbrc.2020.02.071","article-title":"Structure analysis of the receptor binding of 2019-nCoV","volume":"525","author":"Chen","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2025.117841_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ph15030308","article-title":"In silico and in vitro identification of pan-coronaviral main protease inhibitors from a large natural product library","volume":"15","author":"Shahhamzehei","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.biopha.2025.117841_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2020.104137","article-title":"A molecular docking study of EGCG and theaflavin digallate with the druggable targets of SARS-CoV-2","volume":"129","author":"Mhatre","year":"2021","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.biopha.2025.117841_bib12","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41586-023-05905-z","article-title":"Computational approaches streamlining drug discovery","volume":"616","author":"Sadybekov","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.117841_bib13","first-page":"1","article-title":"A review on applications of computational methods in drug screening and design","volume":"25","author":"Lin","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2025.117841_bib14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.12688\/f1000research.29032.2","article-title":"Sustainable data analysis with Snakemake","volume":"10","author":"M\u00f6lder","year":"2021","journal-title":"F1000Research"},{"key":"10.1016\/j.biopha.2025.117841_bib15","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.future.2008.06.012","article-title":"Workflows and e-science: an overview of workflow system features and capabilities","volume":"25","author":"Deelman","year":"2009","journal-title":"Future Gener. Comput. Syst."},{"key":"10.1016\/j.biopha.2025.117841_bib16","doi-asserted-by":"crossref","unstructured":"K.H.D. Crawford, R. Eguia, A.S. Dingens, A.N. Loes, J.D. Bloom, K. Crawford, 2021, Pseudotyping lentiviral particles with SARS-CoV-2 Spike protein for neutralization assays V.2 Coronavirus Method Development Community 2021. https:\/\/doi.org\/10.17504\/protocols.io.br44m8yw..","DOI":"10.17504\/protocols.io.br44m8yw"},{"key":"10.1016\/j.biopha.2025.117841_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.02020","article-title":"Evaluation of neutralizing antibodies against highly pathogenic coronaviruses: a detailed protocol for a rapid evaluation of neutralizing antibodies using vesicular stomatitis virus pseudovirus-based assay","volume":"11","author":"Almahboub","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.biopha.2025.117841_bib18","article-title":"Identification of entry inhibitors against delta and omicron variants of SARS-CoV-2","volume":"23","author":"Lee","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.117841_bib19","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.ajic.2020.07.031","article-title":"Susceptibility of SARS-CoV-2 to UV irradiation","volume":"48","author":"Heilingloh","year":"2020","journal-title":"Am. J. Infect. Control"},{"key":"10.1016\/j.biopha.2025.117841_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.573526","article-title":"A novel In-Cell ELISA assay allows rapid and automated quantification of SARS-CoV-2 to analyze neutralizing antibodies and antiviral compounds","volume":"11","author":"Sch\u00f6ler","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2025.117841_bib21","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.phymed.2016.04.007","article-title":"Cytotoxicity of seven naturally occurring phenolic compounds towards multi-factorial drug-resistant cancer cells","volume":"23","author":"Kuete","year":"2016","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2025.117841_bib22","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.7605","article-title":"Interaction of antihistaminic drugs with human translationally controlled tumor protein (TCTP) as novel approach for differentiation therapy","volume":"7","author":"Seo","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2025.117841_bib23","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1089\/adt.2011.0380","article-title":"Molecular interaction studies using microscale thermophoresis","volume":"9","author":"Jerabek-Willemsen","year":"2011","journal-title":"Assay. Drug Dev. Technol."},{"key":"10.1016\/j.biopha.2025.117841_bib24","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s10637-014-0098-1","article-title":"The ability of molecular docking to unravel the controversy and challenges related to P-glycoprotein - a well-known, yet poorly understood drug transporter","volume":"32","author":"Zeino","year":"2014","journal-title":"Investig. N. Drugs"},{"key":"10.1016\/j.biopha.2025.117841_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102434","article-title":"The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China","volume":"109","author":"Yang","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.biopha.2025.117841_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105076","article-title":"Recent studies of nitrogen containing heterocyclic compounds as novel antiviral agents: a review","volume":"114","author":"Mermer","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.biopha.2025.117841_bib27","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.4c01122","article-title":"An update on the nitrogen heterocycle compositions and properties of U.S. FDA-approved pharmaceuticals (2013-2023)","author":"Marshall","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2025.117841_bib28","doi-asserted-by":"crossref","first-page":"10257","DOI":"10.1021\/jm501100b","article-title":"Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among U.S. FDA approved pharmaceuticals","volume":"57","author":"Vitaku","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2025.117841_bib29","doi-asserted-by":"crossref","DOI":"10.1186\/s43094-021-00335-y","article-title":"Piperidine nucleus in the field of drug discovery","volume":"7","author":"Abdelshaheed","year":"2021","journal-title":"Futur J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2025.117841_bib30","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.2147\/DDDT.S299120","article-title":"Progress of plant medicine derived extracts and alkaloids on modulating viral infections and inflammation","volume":"15","author":"Ti","year":"2021","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.biopha.2025.117841_bib31","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/cbdd.12520","article-title":"Synthesis and preliminary antiviral activities of piperidine-substituted purines against HIV and influenza A\/H1N1 infections","volume":"86","author":"Kang","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.biopha.2025.117841_bib32","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s43440-022-00381-0","article-title":"In vitro antiviral activity of piperidine alkaloids from Senna spectabilis flowers on Chikungunya virus infection","volume":"74","author":"Freitas","year":"2022","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.biopha.2025.117841_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202400384","article-title":"N-benzyl piperidine fragment in drug discovery","author":"Sharma","year":"2024","journal-title":"ChemMedChem"},{"key":"10.1016\/j.biopha.2025.117841_bib34","doi-asserted-by":"crossref","first-page":"6659","DOI":"10.1021\/acs.jafc.6b01772","article-title":"Structural diversity and biological activities of indole diketopiperazine alkaloids from fungi","volume":"64","author":"Ma","year":"2016","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.biopha.2025.117841_bib35","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s12272-013-0107-5","article-title":"Prenylated indole diketopiperazine alkaloids from a mangrove rhizosphere soil derived fungus Aspergillus effuses H1-1","volume":"36","author":"Gao","year":"2013","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.biopha.2025.117841_bib36","doi-asserted-by":"crossref","DOI":"10.1007\/s00253-024-13026-4","article-title":"Novel anti-inflammatory diketopiperazine alkaloids from the marine-derived fungus Penicillium brasilianum","volume":"108","author":"Zhang","year":"2024","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.biopha.2025.117841_bib37","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1021\/acs.jnatprod.1c01120","article-title":"Synthesis and antiviral activities of neoechinulin B and its derivatives","volume":"85","author":"Nishiuchi","year":"2022","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.biopha.2025.117841_bib38","article-title":"2,5-diketopiperazine derivatives as potential anti-influenza (H5N2) agents: synthesis, biological evaluation, and , and molecular docking study","author":"Phutdhawong","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2025.117841_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105820","article-title":"Identification of natural compounds as SARS-CoV-2 entry inhibitors by molecular docking-based virtual screening with bio-layer interferometry","volume":"172","author":"Zhang","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2025.117841_bib40","article-title":"Anti-entry activity of natural flavonoids against SARS-CoV-2 by targeting spike RBD","volume":"14","author":"Meng","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.biopha.2025.117841_bib41","article-title":"Targetable elements in SARS-CoV-2 S2 subunit for the design of pan-coronavirus fusion inhibitors and vaccines","volume":"8","author":"Guo","year":"2023","journal-title":"Signal. Transduct. Target Ther."},{"key":"10.1016\/j.biopha.2025.117841_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28143","article-title":"Pan-coronavirus fusion inhibitors to combat COVID-19 and other emerging coronavirus infectious diseases","volume":"95","author":"Lan","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.biopha.2025.117841_bib43","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aav4580","article-title":"A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike","volume":"5","author":"Xia","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biopha.2025.117841_bib44","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/s41401-021-00735-z","article-title":"Discovery of potential small molecular SARS-CoV-2 entry blockers targeting the spike protein","volume":"43","author":"Wang","year":"2022","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.biopha.2025.117841_bib45","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41422-022-00644-8","article-title":"Structural insights into the SARS-CoV-2 Omicron RBD-ACE2 interaction","volume":"32","author":"Lan","year":"2022","journal-title":"Cell Res."},{"key":"10.1016\/j.biopha.2025.117841_bib46","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.117841_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/s41422-024-00958-9","article-title":"Structural basis for the recognition of HCoV-HKU1 by human TMPRSS2","author":"Xia","year":"2024","journal-title":"Cell Res."},{"key":"10.1016\/j.biopha.2025.117841_bib48","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/cr.2013.92","article-title":"Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4","volume":"23","author":"Wang","year":"2013","journal-title":"Cell Res."},{"key":"10.1016\/j.biopha.2025.117841_bib49","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nature11271","article-title":"Protein activity regulation by conformational entropy","volume":"488","author":"Tzeng","year":"2012","journal-title":"Nature"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225000356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225000356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:49:10Z","timestamp":1762310950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225000356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":49,"alternative-id":["S0753332225000356"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.117841","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diketopiperazine\/piperidine alkaloid as a potential broad-spectrum coronaviral entry inhibitor identified by supercomputer-based virtual screening from a large natural product-based library","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.117841","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117841"}}